ArticlePharmacoEconomics2021
Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of Interest.
Article in PharmacoEconomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Making room for patients in economic evaluation: a commentary on current capacity and future directions.Research involvement and engagement · 2026Article
- Improving Consumer Engagement in Health Technology Assessment and Decision Making: Lessons from 'Values in Science'.Applied health economics and health policy · 2026Review
- The 'Values in Modelling' Framework for Patient and Public Involvement in Health Economics Modelling: Development and Application in the LEAP Model Project.PharmacoEconomics · 2026Review
- Mathematical Modelling for Community Based Intervention for Managing Diabetes: A Systematic Literature Review.Journal of multidisciplinary healthcare · 2025Review
- Improving Transparency of Decision Models Through the Application of Decision Analytic Models with Omitted Objects Displayed (DAMWOOD).PharmacoEconomics · 2024Article
- Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative: implications for decision making.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024Article
- Making Decision Models Fit for Purpose: The Importance of Ensuring Stakeholder Involvement.PharmacoEconomics · 2024Article
- Values in Modelling: Video Series Development and Evaluation Survey.Applied health economics and health policy · 2023Article
- Patient and Public Involvement in Health Economics Modelling Raises the Need for Normative Guidance.PharmacoEconomics · 2023Article
- Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network.PharmacoEconomics · 2022Article
- Four Aspects Affecting Health Economic Decision Models and Their Validation.PharmacoEconomics · 2022Article
- The public and patient involvement imperative in Ireland: Building on policy drivers.Frontiers in public health · 2022Article
- Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling.Social science & medicine (1982) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundPatient involvement in health economics modeling has been advocated on numerous grounds, including as a way to better manage social and ethical value judgments in the modeling process. However, some have pointed to potential risks and variables that could influence the overall benefit of involvement. To inform future research, there is a need to generate knowledge on potential benefits, harms, and variables relevant to patient involvement in health economics modeling.
methodsThis analysis used data from a qualitative study in which 22 health economists were asked their views on the possibility of involving patients in the modeling process. Using qualitative methods, the authors organized participants' responses into theory-driven categories ("potential benefits", "potential harms", "variables of interest") and identified data-driven themes and subthemes within those categories.
resultsFindings point to potential benefits and harms to the model, modeler, patient, and modeling process. Variables of interest relevant to future research included patients' specific roles, modeler and patient characteristics, the goals of modeling, dynamics among participators, and features of high-level procedures. The findings raise a number of specific questions that may be fruitful to explore in future research on patient involvement in health economics modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.